INCA34176-254: A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease (clinicaltrials.gov) - Oct 16, 2026 - P2 | N=130 | Active, not recruiting | Sponsor: Incyte Corporation | Trial completion date: Dec 2029 ➔ Mar 2029 | Trial primary completion date: Jun 2027 ➔ Oct 2026
Trial completion date • Trial primary completion date • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology
|